Robert W Malone MD MS

The original inventor of mRNA and DNA vaccination technologies (1989, with nine issued patents); including DNA and RNA vaccination as well as in-vitro and in-vivo RNA transfection. Dr. Malone is a specialist in clinical research, medical affairs, regulatory affairs, project management, proposal management (large grants and contracts), vaccines and biodefense. This includes writing, developing, reviewing and managing vaccine, bio-threat and biologics clinical trials and clinical development strategies. He has been involved in developing, designing, and providing oversight of approximately forty phase 1 clinical trials and twenty phase 2 clinical trials, as well as five phase 3 clinical trials. He has served as medical director/medical monitor on both phase 1, phase 2 and phase 3 clinical trials, including those run at well-known vaccine-focused Clinical Contract Research Organizations. He has served as principal investigator on some of these. However, having witnessed the corruption and malfeasance by the US Government during the corona crisis, Dr. Malone has come to realize that the whole pubic health and vaccine enterprise must be re-evaluated. Dr. Malone led a large team from January 10, 2020 to March 2022, focused on clinical research design, drug development, computer modeling and mechanisms of action of repurposed drugs for COVID-19 treatment. This work has included multiple manuscripts summarizing most recent findings relating to famotidine and overall insights into the mechanism of COVID-19 disease. Dr. Malone is an internationally recognized scientist and is the original inventor of mRNA Vaccination, DNA Vaccination, and multiple non-viral DNA and RNA/mRNA delivery technologies (mRNA as a drug). Dr. Malone holds numerous fundamental domestic and foreign patents in the fields of gene delivery, delivery formulations, and vaccines: including DNA and RNA/mRNA vaccines. His medical and scientific expertise includes virology, immunology, molecular biology, pathology and pharmacology. Scientifically trained at UC Davis, UC San Diego, and at the Salk Institute Molecular Biology and Virology laboratories, Dr. Malone received his medical training at Northwestern University (MD) and Harvard University (Clinical Research Post Graduate Fellowship) medical schools, and in Pathology at UC Davis. Dr. Malone has approximately 100 peer-reviewed publications and published abstracts and has about 12,000 citations of his peer reviewed publications and patents, as verified by Google Scholar. His google scholar ranking is “outstanding” for impact factors. He has been an invited speaker at over a 100 conferences, has chaired numerous conferences and he has sat on or served as chairperson on numerous NIAID and DoD study sections. Dr. Malone has testified at the US State Senate, the Texas State Senate, the Tennessee State Senate, The Louisiana State Senate and many spoken at many other government entities as well as senators and congress people, both at the state and federal level on risks of the risks of the COVID vaccines and COVID public health policies. Dr. Malone has been featured on many TV shows and podcasts, including Joe Rogan (after which Dr Malone’s episode was the #1 podcast in the world and there have been approx. 100 million listeners for this single podcast), Fox News with Tucker Carlson, the War Room with Steve Bannon, Mercola, Glen Beck, Laura Ingraham, Epoch Times, News Max, OAN, Candice Owens, The American Thinker, The High Wire with Del Bigtree, Lou Dobbs, The Dark Horse Studio and dozens more. Please search Spotify or Apple Podcasts (“Robert Malone”) for listings. He has written editorials for the Washington Times, Trial Site News, The Brownstone Institute and his work has been featured on Real Clear Politics. Most recently he has presented twice at CPAC, at the Heritage Foundation, and as a keynote speaker at the John Birch Society national conference. Dr. Malone’s Substack, "Who is Robert Malone" (rwmalonemd.substack.com) is written almost daily and via direct email reaches 250,000 subscribers. The daily readership of his substack averages around 750,000. These articles are often picked up by aggregator news sites.